Berikutnya

Putar otomatis

Dr. Amaria on Genetically Modified TILs in Melanoma

1 Tampilan • 07/03/23
Membagikan
Menanamkan
administrator
administrator
Pelanggan
0

Rodabe N. Amaria, MD, Department of Melanoma Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, discusses genetically modified tumor infiltrating lymphocytes (TILs) for patients with advanced melanoma.

Menampilkan lebih banyak
0 Komentar sort Sortir dengan
Komentar Facebook

Berikutnya

Putar otomatis